FDA’s Pharmaceutical Regulatory Workload Picks Up In 2013 After Slow 2012
Executive Summary
Congress likely to release $85 million in drug user fees that were taken out of the agency’s fiscal 2013 appropriations by sequestration, but it won’t boost FDA’s overall budget.
You may also be interested in...
Track-and-Trace Bill Clears House With New Electronic Labeling Language
Safeguarding America’s Pharmaceuticals Act passes on suspension calendar, but likely sets up fight with Senate in conference.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.